carlisle & Associates
generic drug updates News contact carlisle medical
news
generic drug updates
Generic Bactroban® Launches
Released: 01/28/2013
By: Mike Partridge, RPh

On January 25, 2013, Glenmark received final FDA approval for and commenced shipping the generic equivalent for GlaxoSmithKline’s branded product, Bactroban® (mupirocin) cream. Bactroban® had estimated total U.S. annual sales of approximately $70 million.
Bactroban is indicated for the treatment of secondarily infected traumatic skin lesions due to susceptible strains of S. aureus and S. pyogenes.


<<Back
 
Company News Releases
Generic Drug Updates
Newsletter Subscription
Newsletter Login
 
 
 
 
 
© Copyright 2019 Carlisle Medical, Inc.
Twitter Twitter Twitter Twitter
disclaimer site map disclaimer